Continuing Education for Hematology | Online CME Hematology Courses

Education

Search

Saved Activities

0 Activities

0 Activities

Filter Content

Page 2 of 3

Results 31 - 60 of 86

Treatment of Ph+ Relapsed/Refractory ALL

Treatment of Ph- Relapsed/Refractory ALL

Emerging Nonfactor Approaches for Patients with Hemophilia

Identification of Relapsed ALL

Principles of Management of Chronic GVHD

Diagnosing and Assessing Chronic Graft-versus-Host Disease

Reversing DOACS: Providing Answers to What, Where and How

Reversing DOACS: Recording from Live Session held on July 18, 2021

Conquer the Clot: Addressing VTE in Your Patients with Cancer

9076-0001-263x149

Healthcare Disparities in African Americans With Myeloma

Key Considerations: Advances in Gene Therapy for Hemophilia

Highlights From the EAHAD 2021 Virtual Congress

Updated Follow-up of the Alta Study, Giroctocogene Fitelparvovec (SB-525)

First Data From the Phase 3 HOPE-B Gene Therapy Trial

The World Federation of Hemophilia Gene Therapy Registry

Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Pipe)

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Leebeek)

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Miesbach)

First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology

Characterisation of Adeno-Associated Virus Vector Persistence

Follow-up on a Novel Adeno-Associated Virus (AAV) Gene Therapy (FLT180a)

Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Drygalski)

Efficacy and Safety of Etranacogene Dezaparvovec in Adults

Thrombotic Thrombocytopenic Purpura (TTP) Podcasts

Cancer-Associated Thrombosis: Catheter-related Thrombosis (CRT) VTE

Approach to the Patient With Cancer-associated VTE

Cancer-Associated Thrombosis: Primary Prophylaxis

Understanding and Recognizing TTP

How to Treat iTTP in 2020

TTP: Complexities and Comorbidities

Page 2 of 3